Cargando…
Plasma-Derived miRNA-222 as a Candidate Marker for Papillary Thyroid Cancer
We analyzed five miRNA molecules (miR-221; miR-222; miR-146b; miR-21; miR-181b) in the plasma of patients with papillary thyroid cancer (PTC), nodular goiter (NG) and healthy controls (HC) and evaluated their diagnostic value for differentiation of PTC from NG and HC. Preoperative PTC plasma miRNA e...
Autores principales: | Kondrotienė, Aistė, Daukša, Albertas, Pamedytytė, Daina, Kazokaitė, Mintautė, Žvirblienė, Aurelija, Daukšienė, Dalia, Simanavičienė, Vaida, Klimaitė, Raimonda, Golubickaitė, Ieva, Stakaitis, Rytis, Šarauskas, Valdas, Verkauskienė, Rasa, Žilaitienė, Birutė |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503340/ https://www.ncbi.nlm.nih.gov/pubmed/32899424 http://dx.doi.org/10.3390/ijms21176445 |
Ejemplares similares
-
Papillary Thyroid Carcinoma Tissue miR-146b, -21, -221, -222, -181b Expression in Relation with Clinicopathological Features
por: Kondrotienė, Aistė, et al.
Publicado: (2021) -
MON-LB82 Plasma Expression Level of MiRNA -21 Is Related With the Presence of Papillary Thyroid Cancer
por: Zilaitiene, Birute, et al.
Publicado: (2020) -
SAT-LB096 Relationship between MicroRNA Expression Levels and Clinicopathological Parameters and Recurrence of Papillary Thyroid Carcinoma
por: Pamedytyte, Daina, et al.
Publicado: (2019) -
Association of microRNA Expression and BRAF(V600E) Mutation with Recurrence of Thyroid Cancer
por: Pamedytyte, Daina, et al.
Publicado: (2020) -
The Role of TSHR, PTEN and RASSF1A Promoters’ Methylation Status for Non-Invasive Detection of Papillary Thyroid Carcinoma
por: Klimaitė, Raimonda, et al.
Publicado: (2022)